eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
Clinical trial NCT05427240 · RECRUITING
Trial details
- NCT number
- NCT05427240
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-28
- Primary completion
- 2025-12-24
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.